Departments & Organizations
Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Medicine, Pharmacology, and Physiology: Cancer Biology and Therapeutics; Human Disease Pathology, Physiology and Intervention; Receptors and Signal Transduction
Marcus Bosenberg M.D., Ph.D., is a physician scientist who directs a leading melanoma research laboratory, is Co-Leader of the Genomics, Genetics and Epigenetics Program of the Yale Cancer Center, Co-Director of the Yale SPORE in Skin Cancer, and is a practicing dermatopathologist at Yale Dermatopathology in the Yale Medical Group.
In his research, Dr. Bosenberg studies the genetics and cellular changes that result in melanoma, the leading cause of skin cancer deaths. His laboratory has developed several widely utilized mouse models in order to study how melanoma forms and progresses, to test new melanoma therapies, and how the immune system can be stimulated to fight melanoma. He works to translate basic scientific findings into improvements in melanoma diagnosis and therapy. He has published over 100 peer-reviewed articles, is a member of the Yale Cancer Center Executive Committee, and is a faculty member of the Raymond and Beverly Sackler Institute for Biological, Physical, and Engineering Sciences.
Dr. Bosenberg mentors undergraduate, graduate, medical, and MD-PhD students in his laboratory, teaches at Yale Medical School, and trains resident physicians, fellows, and postdoctoral fellows.
Education & Training
|MD||Cornell University Medical College (1994)|
|PhD||Cornell University Medical College (1993)|
|BA||Cornell University (1986)|
|Research Fellow||Dana-Farber Cancer Institute|
|Fellow||Harvard Medical School Dermatopathology Training Program|
|Chief Resident||Brigham & Women's Hospital|
|Resident||Brigham & Women's Hospital|
|Research Fellow||University of Wisconsin|
|Board Certification||AB of Pathology, Anatomic Pathology (2000)|
|Board Certification||AB of Pathology, Dermatopathology (2001)|